In “Acknowledgments” on page 5571, NIH/National Heart, Lung, and Blood Institute grant OT3HL147741 should not have been cited. The error has been corrected in the published article.
© 2021 by The American Society of Hematology
2021
Advertisement
Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.. Blood Adv 2021; 5 (11): 2518. doi: https://doi.org/10.1182/bloodadvances.2021005068
Download citation file:
In “Acknowledgments” on page 5571, NIH/National Heart, Lung, and Blood Institute grant OT3HL147741 should not have been cited. The error has been corrected in the published article.
Advertisement
Advertisement
Advertisement
Advertisement